Want to join the conversation?
$HES 2Q15 PR: HES today reported total revenues and non-operating income of $1,935MM, down 46.2% vs. $3,600MM in 2Q15. Net loss was $567MM compared to net income of $931MM in 2Q14. Capital and exploratory expenditures totaled $1.1Bil down from $1.3Bil in 2Q14. Loss per share was $1.99 vs. EPS of $2.96 in 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?